Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data
Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data DENVER, Sept. 22, 2021
September 22, 2021
Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data DENVER, Sept. 22, 2021
Blackhawk Growth’s MindBio Therapeutics Plans to Commercialize Intellectual Property Generated from the University of Auckland’s
Allied Corp. Advances Psilocybin Product Psilonex™ RX and Initiates Manufacturing Process Allied Corp. (ALID) has
Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014,
Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its Drugs to Differentiate Between
Washington Officials Join Cancer Patients In Federal Court Argument Pushing DEA To Allow Psilocybin Access
Meet the women who regularly microdose psychedelics Three women struggling with mental health issues shared
Moms who microdose ‘magic’ mushrooms say the psychedelic made them better parents Moms around
This Psychedelics Stock Could Grow 300% In One Year Experts predict major growth for this
Minnesota Psychedelic Therapy Clinic, Institute for Integrative Therapies, Begins Offering Psychedelic Therapy in a Group
Cannabis Firm Plans South Africa IPO, Magic Mushroom Expansion South Africa’s first cannabis company is
Diamond Therapeutics Announces Health Canada Approval of Clinical Trial with Low-Dose Psilocybin There’s tremendous anecdotal
Ground-breaking research to explore the potential for psilocybin to treat traumatic brain injury This Fall,
B.C. health researchers harness the ‘magic’ of psychedelic mushrooms After beating cancer, Mona Strelaeff suffered
Dr. Jennifer Miller | Principal Investigator, Tryp Therapeutics Tryp Therapeutics Inc. (TRYP), is conducting a
Diamond Therapeutics contracts BioPharma Services for Phase 1 clinical trial While there have been few
Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic Molecule CYB004 Cybin Inc. (CYBN) announced that
Cybin Launches EMBARK and Co-Sponsors First Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Burnout
Why Is Ottawa Stalling Proven Magic Mushroom Therapy for the Dying? After two psilocybin-assisted therapy
Psilocybin May Reduce Suicidal Thoughts in Terminally Ill Patients, Suggests New Study A recent NYU
New York Bill Would Create State-Sponsored Psychedelics Research Institute A new bill proposed in New
What psychedelics taught me about healing trauma The psychedelic treatment revolution is shifting the model
Cancer patients in drug therapy experience If cancer patients have the right to end their